| Bioactivity | Oxiracetam is a cyclic derivative of γ-aminobutyric acid (GABA) which has been commonly used as nootropic drug to treat cognitive impairments. | ||||||||||||
| Target | GABA receptor | ||||||||||||
| Name | Oxiracetam | ||||||||||||
| CAS | 62613-82-5 | ||||||||||||
| Formula | C6H10N2O3 | ||||||||||||
| Molar Mass | 158.16 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Li W, et al. (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. Sci Rep. 2017 Aug 30;7(1):10052. |